While many feel an immediate surge, some experience a healing crisis or detox fatigue
Contact your GP if you experience dizziness, light-headedness, or fainting, as medication adjustments may be needed to prevent excessive blood pressure lowering
We can answer all your questions so you're confident you take all the proper steps
[3] As of mid-2025, retatrutide has not been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA) for use in the UK or Europe
In upcoming studies, researchers will evaluate long-term safety data
While Novo Nordisk and rival obesity therapy manufacturer Eli Lilly are starting to overcome the production constraints that coupled with massive demand have resulted in shortages, Noom's WSJ ad calls for US policymakers to keep the status in place "until GLP-1s cost the same in NYC and London." The FDA has received adverse event reports involving patients who have used them and has taken action against some compounders making versions available based on salt forms of the drug that are unapproved, including semaglutide sodium and semaglutide acetate, so the availability of compounded forms has become controversial